Posts tagged sickle cell treatment
The tl;dr Pharmacy Journal Club: Voxelotor in Sickle Cell Disease (HOPE Trial)
The tl;dr Pharmacy Journal Club: Voxelotor in Sickle Cell Disease (HOPE Trial)

It’s journal club time! If you've been paying attention to the news this week, you probably saw that Pfizer is voluntarily withdrawing Oxbryta (voxelotor) from the market due to safety concerns. This is an inherent (and unfortunate) risk for drugs approved under the FDA's accelerated approval pathway. Even though the drug itself bit the dust, this journal club still holds up!

Read More
Clinical, Pharmacy School, Practice, ResidencyCourtney Howellsickle cell disease, hemoglobin S, vasoocclusive crisis, voxelotor, journal club, what is sickle cell anemia, sickle cell disease pharmacy, sickle cell disease for pharmacists, sickle cell management, sickle cell treatment, sickle cell anemia, sickle cell pathophysiology, what is hemoglobin, hemoglobin vs hemoglobin S, complications of sickle cell anemia, sickle cell complications, treatment of sickle cell disease, sickle cell anemia treatment, HOPE trial journal club, voxelotor journal club, tldr journal club
The Pharmacist's Guide to Sickle Cell Disease
The Pharmacist's Guide to Sickle Cell Disease

For most pharmacists, encounters with sickle cell disease are few and far between. However, if you work in a city (particularly if it's an international hub such as DC or New York), you will encounter sickle cell somewhat regularly.

Read More
Clinical, Pharmacy School, Practice, ResidencyBrandon Dysonsickle cell, sickle cell disease, sickle cell anemia, hydroxyurea, the pharmacist's guide to sickle cell disease, sickle cell treatment, sickle cell management, stem cell transplant, hematopoietic stem cell transplant, allogeneic, autologous, PCV13, PPSV23, nutrition in sickle cell disease, infection prevention in sickle cell disease, pain management in sickle cell disease, sickle cell disease pharmacy, sickle cell disease for pharmacists, acute chest syndrome, endari, l-glutamine